bioMerieux (OTCMKTS:BMXMF) Share Price Crosses Below 50-Day Moving Average – Here’s What Happened
by Doug Wharley · The Cerbat GembioMerieux (OTCMKTS:BMXMF – Get Free Report)’s share price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $128.44 and traded as low as $125.00. bioMerieux shares last traded at $125.00, with a volume of 303 shares changing hands.
bioMerieux Stock Performance
The company has a current ratio of 2.27, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08. The stock has a fifty day moving average of $128.44 and a two-hundred day moving average of $135.95.
About bioMerieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Articles
- Five stocks we like better than bioMerieux
- How Technical Indicators Can Help You Find Oversold Stocks
- Worried About Inflation? These 3 ETFs Offer Real Protection
- Upcoming IPO Stock Lockup Period, Explained
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- How to Read Stock Charts for Beginners
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem